Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Importers Notice of Application - 2021

Importers Notice of Application - 2021

Royal Emerald Pharmaceuticals (April 5, 2021)

Sharp Clinical Services, Inc. (April 1, 2021)

Shertech Laboratories, LLC (March 24, 2021)

Medi-Physics Inc. dba GE Healthcare (March 24, 2021)

Perkinelmer, Inc. (March 24, 2021)

Purisys, LLC (March 16, 2021)

Stepan Company (March 2, 2021)

Groff NA Hemplex, LLC (March 1, 2021)

Microgenics Corporation Thermo Fisher Scientific (March 1, 2021)

Myonex Inc. (February 25, 2021)

Globyz Pharma, LLC (February 24, 2021)

VHG Labs DBA LGC Standards (February 19, 2021)

S and B Pharma, Inc. (February 16, 2021)

Noramco Coventry, LLC (February 16, 2021)

Sigma Aldrich Co., LLC (February 16, 2021)

Siegfried USA, LLC (February 16, 2021)

Mylan Pharmaceuticals Inc. (February 4, 2021)

Indigenous Peyote Conservation Initiative (January 28, 2021)

Medi-Physics, Inc. dba GE Healthcare (January 12, 2021)

S&B Pharma LLC dba Norac Pharma (January 12, 2021)

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
Search for Year Round Pharmaceutical Disposal Locations.
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility